Table 3.
Adverse outcomes stratified by use of anti-tumor necrosis factor (anti-TNF) medication.
Anti-TNF Users
Nonusers
• 4 Infections; 3 cellulitis and 1 deep joint infection
• 3 Infections; all cellulitis
• 1 Pneumonia
• 4 Pneumonias
• 2 Revisions
• 2 Deep vein thromboses
• 1 Revision